Physician profile
Ellen Kapiloff
NPI 1841315199
$2,330.70
in general payments reported to CMS, 2019-2025
18 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $154 · 2021: $72.47 · 2022: $747 · 2023: $598 · 2024: $368 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098 · Entertainment: $20.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.73 |
| Entertainment | $20.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $977.63 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $562.73 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Lumenis Be INC | $152.33 | 2022 | |
| Lkc Technologies, INC. | $99.14 | 2024 | |
| Maculogix, INC. | $95.44 | 2020 | |
| Abb Con-Cise Optical Group LLC | $74.91 | 2022-2023 | Spectacle Lenses, Contact Lens |
| Bausch & Lomb Americas INC. | $62.31 | 2023-2024 | Infuse, Miebo |
| Dompe US, INC. | $59.99 | 2023 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $49.26 | 2021-2022 | |
| New World Medical,INC. | $44.06 | 2019 | |
| Visioneering Technologies, INC. | $30.70 | 2019 | |
| Allergan, INC. | $25.97 | 2022 | |
| Optos, INC. | $20.69 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $17.40 | 2024 | Xdemvy |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.29 | 2020 | |
| Oyster Point Pharma, INC. | $13.96 | 2022 | |
| Kala Pharmaceuticals, INC. | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Kapiloff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.